Glenview Capital Management
Glenview Capital Management is a $7 billion hedge fund under the management of Larry Robbins. The $7 billion is split between Glenview Funds, a short fund, and Little Arbor Funds, a multi-strategy fund. Robbins makes his returns making concentrated bets on large cap stocks. In addition, Robbins has been known to take a more activist approach to some of his large bets, voicing concerns about what management is doing and publicly demanding change. In 2005, Glenview returned more than 15% to its investors, earning Robbins a large fee and making him one of the top paid managers on Wall Street.
-
StreetInsider.com Pre-Open Movers 6/13: (BLC) (GCI) (SWY) Higher; (SGOC) (SIGM) (ELN) Lower (more...)
-
Streetinsider.com After-Hours Movers 06/12: (SWY) (SRPD) (PVH) Higher; (SIGM) (MW) Lower (more...)
-
Health Management (HMA) Affirms Discussions with Advisors
-
Unusual 11 Mid-Day Movers 06/12: (CERE) (CTB) (ULTA) Higher; (CLSN) (KNDI) (LEDS) Lower
-
Glenview Capital Asks Health Management (HMA) to Redeem 'Poison Pill' Provision
-
Perfect Storm of Events Has Health Management (HMA) in M&A Spotlight (CYH)
-
Health Management (HMA) Higher; Investors Anticipate Change
-
Health Management Associates (HMA) Adopts Poison Pill Provision
-
Glenview Capital Raises Stake in Health Management (HMA) to 14.58% - 13D
-
ITC Holdings (ITC) Lower on Robbins Comments, Tenet Healthcare (THC) Higher
-
Glenview Capital Raises Stake in Health Management Associates Inc. (HMA) to 5%
-
Glenview Capital Shows New Stakes in BofA (BAC), AIG (AIG) and Crown Castle (CCI); Sells CVS (NYSE: CVS), Pfizer (PFE)
